Who invested in Tokai Pharmaceuticals?
Tokai Pharmaceuticals's investors include Novartis Venture Fund and Apple Tree Partners.
United States · Venture startup
4 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$100Mraised across 4 rounds since 2009, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by fiercebiotech.comSEC filing: $20M sold, first sale May 2013
No investor was named in the report.
Reported by sec.govSEC filing: $20M sold, first sale May 2013
Reported by eon.businesswire.comSEC filing: $1.9M sold, first sale Sept 2011
Reported by onbiovc.comSEC filing: $10M sold, first sale May 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Tokai Pharmaceuticals's investors include Novartis Venture Fund and Apple Tree Partners.
Tokai Pharmaceuticals has raised $100M across 4 rounds since 2009.
Tokai Pharmaceuticals's most recent round was a Venture of $20M in May 2013.
Tokai Pharmaceuticals's largest round on record is $36M (Series E), in May 2013.
Tokai Pharmaceuticals's first round on record, in Jun 2009, was backed by Novartis Venture Fund and Apple Tree Partners.
Tokai Pharmaceuticals's latest named round is a Venture, in May 2013.
Tokai Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.